Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple pill replace the IV drip for ER infections?

NCT ID NCT06715306

Disease control Sponsor: University of Southern Denmark Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving oral antibiotics instead of IV antibiotics is just as safe and effective for patients with common infections like pneumonia, urinary tract infections, and cellulitis. About 4,000 adults in Danish emergency rooms will be randomly assigned to start oral antibiotics right away or continue with IV treatment. The goal is to see if oral treatment can keep patients healthy and out of the hospital just as well as IV, potentially allowing many to go home sooner.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
oral antibiotics
What this could lead to
If oral antibiotics work as well as IV, many patients could be treated at home or discharged sooner, saving hospital resources and reducing time away from home.
What could go wrong
This is a large trial but still testing whether oral antibiotics are safe and effective enough for patients who would normally get IV. Some patients may need IV if oral fails or causes side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 4,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Suspected respiratory tract infection, urinary tract infection, or cellulitis by the attending physician * Planned or initiated intravenous antibiotic treatment Exclusion Criteria: * if received more than two doses of intravenous antibiotics; * systolic blood pressure \<90 mmHg; * nausea and/or vomiting in more than one short-term instance during the last 2 days; * suspected significantly reduced gastrointestinal absorption; * confirmed plasma-lactate \> 2; * pregnant or nursing; * unable to give informed consent; * severe immunodeficiency; * urgent vital treatment needed.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cellulitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cellulitis respiratory tract infectious disorder urinary tract infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cellulitis Respiratory tract infections Urinary tract infections

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Amager and Hvidovre Hospital

    ACTIVE_NOT_RECRUITING

    Hvidovre, 2650, Denmark

  • Bispebjerg and Frederiksberg Hospital

    ACTIVE_NOT_RECRUITING

    Copenhagen, 2400, Denmark

  • Esbjerg and Grindsted Sygehus

    RECRUITING

    Esbjerg, 6700, Denmark

  • Herlev and Gentofte Hospital

    ACTIVE_NOT_RECRUITING

    Herlev, 2730, Denmark

  • Nordsjællands Hospital

    RECRUITING

    Copenhagen, Denmark

  • Sygehus Lillebælt

    RECRUITING

    Kolding, 6000, Denmark

  • Sygehus Sønderjylland

    RECRUITING

    Aabenraa, Southern Denmark, 6200, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.